Claris Life Gets USFDA Nod For Generic Anesthetic Injection

New Delhi: Drug firm Claris Lifesciences has received approval from the US health regulator for generic anesthetic Bupivacaine injection. The company has received approval from the United States Food and Drug Administration (USFDA) for generic "Bupivacaine hydrochloride in 8.25 per cent dextrose injection USP 7.5 mg/mL, single dose ampules with 2 ml fill volumes," Claris Lifesciences said in a BSE filing. The injection is indicated...